On October 28, 2025, the State of Texas filed a complaint against Johnson & Johnson and Kenvue, Inc. (“Kenvue”)—formerly the…
Read More →
Pfizer Inc. is facing a growing number of lawsuits from patients who received Depo Provera injections—including patients who received their…
Read More →
Stephen Anstey, a Government Relations & Regulatory attorney and registered federal lobbyist in our Washington, D.C. office, shares a brief…
Read More →
AI tools are now a valuable part of the day-to-day toolkit for many teams. The rewards can be great. They…
Read More →
For autologous cell and gene therapies (CGTs), the collection of patients‘ cells is the first step in the manufacture of…
Read More →
In June 2025, the US Food and Drug Administration (FDA) issued a final guidance titled Cybersecurity in Medical Devices: Quality…
Read More →
This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating…
Read More →
Kilpatrick’s Evan Nadel recently presented at the 2025 ANA Masters of Advertising Law Conference on the topic of “Federal Court…
Read More →
Hardened kernel, remote integrity monitoring, an enhanced anti-malware engine, and more.…
Read More →
Sophos Firewall uses intelligent TLS inspection and AI-powered analysts to reveal hidden threats — without compromising performance. …
Read More →